SCHEMBL7135259

SCHEMBL7135259

CC(C)CCn1c(=O)cc(O)c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.68
KDM4E B2RXH2 8/20 0.66
SMN1; SMN2 Q16637 5/20 0.58
KMT2A Q03164 4/20 0.58
MEN1 O00255 3/20 0.58
MAPT P10636 3/20 0.58
HTR3E A5X5Y0 1/20 0.53
HTR3B O95264 1/20 0.53
HTR3A P46098 1/20 0.53
HTR3D Q70Z44 1/20 0.53
HTR3C Q8WXA8 1/20 0.53
POLB P06746 1/20 0.51
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5435816 0.84 KDM4E (0.63) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL7462175 0.83 ALDH1A1 (0.83) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL7437043 0.82 HTR3E (0.61) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL11828707 0.81 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL1790843 0.81 ALDH1A1 (1.00) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL11826856 0.80 ALDH1A1 (0.68) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL9535544 0.80 KDM4E (1.00) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL9262842 0.78 ALDH1A1 (0.89) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL9254043 0.78 ALDH1A1 (0.89) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL30197876 0.78 ALDH1A1 (0.89) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059356-A2 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-07-24 WO claimed